Coughlins closing line on the GLP-1 category captured the strategic logic: Were not interested in kind of me-too entries. With Entresto facing generic erosion and Leqvio soon confronting oral PCSK9 competition from Mercks Enlicitide, Novartis is staking its cardiovascular future on mechanisms that sit adjacent to not inside the metabolic pathway that everyone else is chasing
Severe adverse events remain rare in clinical practice: sporadic acute pancreatitis, gallbladder-related discomfort or injection-site redness only happen in individual susceptible populations
In a streptozotocin-induced diabetic rat model, C
Ferroptosis: a regulated cell death Nexus linking metabolism, redox biology, and disease
However, using GLP-1 as a drug posed a major challenge: The hormone underwent rapid metabolism, remaining in the blood for only a few minutes
The Hybrid Approach: Some Richmond residents employ both methods strategicallyusing injections to rapidly correct deficiency and restore optimal levels, then maintaining those levels with carefully selected oral supplements between injections